145
Participants
Start Date
August 31, 2006
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Family-Focused Treatment Plus Pharmacotherapy
Participants assigned to FFT will take part in weekly treatment sessions with their families for 12 weeks, biweekly for 12 weeks, monthly for 3 months, and then trimonthly until Month 24. Medications used for the pharmacotherapy portion of the study will include mood stabilizers, such as lithium or divalproex sodium, and atypical antipsychotics, such as quetiapine. Participants will also receive anti-anxiety medications, psychostimulants, or antidepressants as needed.
Enhanced Care Plus Pharmacotherapy
Participants assigned to Enhanced Care will take part in weekly brief psychoeducation sessions for 3 weeks. The pharmacotherapy treatment will be the same as for the FFT participants.
University of Pittsburgh Medical Center Western Psychiatric Institute, Pittsburgh
Cincinnati Children's Hospital Medical Center/MLC 3014, Cincinnati
University of Colorado, Dept. of Psychology, Boulder
National Institute of Mental Health (NIMH)
NIH
University of California, Los Angeles
OTHER